On May 21, 2021, TSD Life Sciences Co.,Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,390 KRW | -1.81% | -1.73% | -15.75% |
1st Jan change | Capi. | |
---|---|---|
-15.75% | 191M | |
-19.60% | 11.29B | |
+64.70% | 3.91B | |
-31.09% | 2.29B | |
-10.77% | 2.23B | |
-26.86% | 1.61B | |
+35.42% | 1.19B | |
-2.40% | 752M | |
-35.10% | 458M | |
+14.91% | 338M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.